Skip to content
10-K

Annual Report

Acurx Pharmaceuticals, Inc. ACXP

0001558370-25-003117

← back to feed
Filed
Mar 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 17, 2025 22.04M sh
Shares Diluted FY 2024 · Dec 31, 2023 12.67M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$9.8M
Current Liabilities FY 2024 · Dec 31, 2023 $3.04M
Total Liabilities FY 2024 · Dec 31, 2023 $3.04M
Total Assets FY 2024 · Dec 31, 2023 $7.71M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.15
Eps Basic FY 2024 · Dec 31, 2023 −$1.15
Rd Expense FY 2024 · Dec 31, 2023 $6.04M
Net Income FY 2024 · Dec 31, 2023 −$14.58M
Stockholders Equity FY 2024 · Dec 31, 2022 $7.32M